DanielWillemHommesMDPhD
Gastroenterology • Los Angeles, CAProfessor, Medicine, University of California Los Angeles David Geffen SOM
Are you Dr. Hommes?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 24 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 Medical Plz
365 A
Los Angeles, CA 90095Phone+1 310-825-1597Fax+1 310-794-9718- Is this information wrong?
Summary
- Dr. Daniel Hommes, MD is a gastroenterologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is a Professor at University of California Los Angeles David Geffen SOM.
Education & Training
University of Amsterdam Faculty of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 2011 - 2019
Clinical Trials
- Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease Start of enrollment: 2010 Jun 01
- Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment Start of enrollment: 2014 Feb 01
- OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome Start of enrollment: 2017 Feb 28
Publications & Presentations
PubMed
- 8 citationsArtificial Intelligence for Inflammatory Bowel Diseases (IBD); Accurately Predicting Adverse Outcomes Using Machine Learning.Aria Zand, Zack Stokes, Arjun Sharma, Welmoed K van Deen, Daniel Hommes> ;Digestive Diseases and Sciences. 2022 Oct 1
- 5 citationsPatient Experience and Satisfaction with an e-Health Care Management Application for Inflammatory Bowel DiseasesAria Zand, Audrey Nguyen, Courtney Reynolds, Ariela Khandadash, Eric Esrailian, Daniel W. Hommes> ;International Journal of Environmental Research and Public Health. 2021 Nov 9
- 3 citationsHealth outcomes and experiences of direct-to-consumer high-intensity screening using both whole-body magnetic resonance imaging and cardiological examinationDaniel W. Hommes, Derk Klatte, Wilma Otten, M. Beltman, Günter Klass, Aria Zand, René Sprangers> ;Plos One. 2020 Nov 20
- Join now to see all
Press Mentions
InterVenn Biosciences to Present Clinical Data on Circulating Serum Glycoproteins for Unprecedented Pre-Cancer Detection as “Poster of Distinction” at Digestive Disease Week 2023April 19th, 2023- DEARhealth Becomes One of the World’s First Companies to Obtain CE-Marking According to New European Union Medical Device Regulation (MDR)June 10th, 2021
- DEARhealth Recruits Senior Executives to Accelerate GrowthMarch 30th, 2021
Other Languages
- Dutch, Spanish
